Chantal Miklosi, Chief Financial Officer

Professional Overview

Chantal Miklosi is an accomplished Chief Financial Officer with a proven track record of driving financial strategy and operational excellence across the biotechnology and pharmaceutical industries. With expertise in financial planning, risk management, and strategic decision-making, she has played a crucial role in the growth and success of several innovative companies.

Experience Summary

Current Roles

Chief Financial Officer, Optina Diagnostics (2014-09-01 to Present)

Oversees all financial operations, including budgeting, forecasting, and reporting

Leads the implementation of financial controls and systems to ensure efficient and compliant business practices

Plays a strategic role in driving the company's expansion and securing funding for research and development initiatives

Managing Director, AGEA Management (2012-01-01 to Present)

Provides financial advisory services and strategic consulting to early-stage biotechnology and pharmaceutical companies

Assists clients in developing financial models, securing funding, and optimizing operational efficiency

Chief Financial Officer, Mage Biologics Inc. (2023-07-01 to Present)

Responsible for managing the company's financial operations, including financial reporting, budgeting, and cash flow management

Collaborates with the executive team to develop and implement strategic financial initiatives to support the company's growth

Chief Financial Officer, Recurv Pharma Inc. (2022-11-01 to Present)

Oversees all financial aspects of the company, including financial planning, reporting, and compliance

Plays a key role in securing funding and managing investor relationships to support the company's drug development pipeline

Chief Financial Officer, Auricula Biosciences Inc. (2021-12-01 to Present)

Responsible for leading the company's financial strategy and operations, including financial reporting, budgeting, and cash flow management

Collaborates with the executive team to identify opportunities for cost optimization and operational efficiency

Career Progression

Prior to her current roles, Chantal held various finance leadership positions in the biotechnology and pharmaceutical sectors, including stints as the Chief Financial Officer at Mage Biologics Inc. and Recurv Pharma Inc. Her experience spans across financial planning, risk management, and strategic decision-making, contributing to the growth and success of her employer organizations.

Academic Background

Chantal holds a Master of Business Administration (MBA) from the University of Texas at Austin, where she specialized in Finance and Accounting. She also earned a Bachelor of Science (B.S.) in Biochemistry from the University of California, Los Angeles (UCLA), demonstrating her strong academic foundation in both business and science.

Areas of Expertise

Financial planning and analysis

Budgeting and forecasting

Financial reporting and compliance

Risk management and mitigation

Strategic decision-making

Mergers and acquisitions

Fundraising and investor relations

Biotechnology and pharmaceutical industry knowledge

Professional Impact

Throughout her career, Chantal has played a pivotal role in driving financial strategy and operational excellence for her employer organizations. She has successfully implemented financial controls and systems, optimized operational efficiency, and secured critical funding to support research and development initiatives. Chantal's expertise and leadership have contributed to the growth and success of several innovative biotechnology and pharmaceutical companies.

Conclusion

Chantal Miklosi is a strategic and results-oriented Chief Financial Officer with a proven track record of driving financial success in the biotechnology and pharmaceutical industries. Her strong financial acumen, industry expertise, and collaborative leadership style make her a valuable asset to the companies she serves. Chantal's commitment to continuous improvement and her ability to navigate complex financial challenges positions her as a trusted financial leader in the dynamic and innovative healthcare sector.